As of 2026-10-05, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (147.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.68 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1796.9%.
The range of the Relative Valuation is (139.61) - (142.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.1x - 38.9x | 34.0x |
| Forward P/E multiples | 25.0x - 29.8x | 27.4x |
| Fair Price | (139.61) - (142.97) | (147.29) |
| Upside | -1708.4% - -1747.1% | -1796.9% |
| Date | P/E |